keyword
https://read.qxmd.com/read/38566008/single-intravenous-dose-ondansetron-induces-qt-prolongation-in-adult-emergency-department-patients-a-prospective-observational-study
#21
JOURNAL ARTICLE
Mohammad Rezaei Zadeh Rukerd, Fatemeh Rafiei Shahrbabaki, Mitra Movahedi, Amin Honarmand, Pouria Pourzand, Amirhossein Mirafzal
BACKGROUND: Ondansetron is one of the most commonly used drugs in the emergency department (ED) for treating nausea and vomiting, particularly in intravenous (IV) form. Nevertheless, it has been shown to prolong QT interval and increase the risk of ventricular dysrhythmias. This study evaluated the associations between single IV ondansetron dosage and subsequent QTc prolongation in the ED. METHODS: In this prospective observational study, a total number of 106 patients presenting to the ED in a 3-month period with nausea and vomiting treated with IV ondansetron were enrolled...
April 2, 2024: International Journal of Emergency Medicine
https://read.qxmd.com/read/38565056/the-ion-channel-basis-of-pharmacological-effects-of-amiodarone-on-myocardial-electrophysiological-properties-a-comprehensive-review
#22
REVIEW
Illia Gelman, Neelakshi Sharma, Olivia Mckeeman, Peter Lee, Noah Campagna, Nicole Tomei, Adrian Baranchuk, Shetuan Zhang, Mohammad El-Diasty
Amiodarone is a benzofuran-based class III antiarrhythmic agent frequently used for the treatment of atrial and ventricular arrhythmias. The primary target of class III antiarrhythmic drugs is the cardiac human ether-a-go-go-related gene (hERG) encoded channel, KCNH2, commonly known as HERG, that conducts the rapidly activating delayed rectifier potassium current (IKr ). Like other class III antiarrhythmic drugs, amiodarone exerts its physiologic effects mainly through IKr blockade, delaying the repolarization phase of the action potential and extending the effective refractory period...
April 1, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38555581/naphazoline-abuse-a-rare-case-of-myocardial-infarction-with-nonobstructive-coronary-arteries
#23
JOURNAL ARTICLE
Michele Galasso, Cristina Cavallotti, Cristina Giannattasio, Patrizia Pedrotti
Nasal vasoconstrictors are some of the most widely used over-the-counter drugs, considered by many consumers as relatively safe with few significant adverse effects. At recommended dosage, the drug produces local vasoconstriction in nasal mucous membranes. However, the use of such drugs has been linked to cardiovascular adverse effects, including hypertension, arrhythmias, prolongation of the QT interval, and angina pectoris.1 The various cardiovascular adverse effects may occur with both oral and nasal administration and after a single dose or prolonged treatment, without dose-effect and independently of vascular status and age...
March 27, 2024: Journal of Cardiovascular Medicine
https://read.qxmd.com/read/38546223/population-specific-variations-in-kcnh2-predispose-patients-to-delayed-ventricular-repolarization-upon-dihydroartemisinin-piperaquine-therapy
#24
JOURNAL ARTICLE
Mahamadou D Camara, Yitian Zhou, Antoine Dara, Mamadou M Tékété, Taís Nóbrega de Sousa, Sékou Sissoko, Laurent Dembélé, Nouhoun Ouologuem, Amadou Hamidou Togo, Mohamed L Alhousseini, Bakary Fofana, Issaka Sagara, Abdoulaye A Djimde, Pedro J Gil, Volker M Lauschke
Dihydroartemisinin-piperaquine is efficacious for the treatment of uncomplicated malaria and its use is increasing globally. Despite the positive results in fighting malaria, inhibition of the Kv11.1 channel (hERG; encoded by the KCNH2 gene) by piperaquine has raised concerns about cardiac safety. Whether genetic factors could modulate the risk of piperaquine-mediated QT prolongations remained unclear. Here, we first profiled the genetic landscape of KCNH2 variability using data from 141,614 individuals. Overall, we found 1,007 exonic variants distributed over the entire gene body, 555 of which were missense...
March 28, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38544883/qtc-interval-prolongation-and-its-association-with-electrolyte-abnormalities-and-psychotropic-drug-use-among-patients-with-eating-disorders
#25
JOURNAL ARTICLE
Myles Benayon, Lekhini Latchupatula, Emily Kacer, Maaz Shanjer, Ethan Weiss, Shawnee Amar, Noah Zweig, Mehran Ghadim, Robert Portman, Narayanaswamy Balakrishnan, Hon Yiu So, Sheri Findlay, Natasha Johnson, Tapas Mondal
BACKGROUND: Eating disorders (EDs) often develop during adolescence with high mortality rates. Sudden cardiac death in these patients has been associated with corrected QT (QTc) interval prolongation. The significance of extrinsic factors on QTc prolongation in populations with EDs remains controversial. This study assessed the relationship between QTc prolongation in paediatric patients with EDs and extrinsic factors, such as QTc-prolonging medications and electrolyte abnormalities to investigate whether an ED alone is associated with an increased prevalence of QTc prolongation...
February 2024: CJC Pediatr Congenit Heart Dis
https://read.qxmd.com/read/38541723/cardio-oncoimmunology-cardiac-toxicity-cardiovascular-hypersensitivity-and-kounis-syndrome
#26
JOURNAL ARTICLE
Nicholas G Kounis, Ming-Yow Hung, Cesare de Gregorio, Virginia Mplani, Christos Gogos, Stelios F Assimakopoulos, Panagiotis Plotas, Periklis Dousdampanis, Sophia N Kouni, Anastasopoulou Maria, Grigorios Tsigkas, Ioanna Koniari
Cancer therapy can result in acute cardiac events, such as coronary artery spasm, acute myocardial infarction, thromboembolism, myocarditis, bradycardia, tachyarrhythmias, atrio-ventricular blocks, QT prolongation, torsades de pointes, pericardial effusion, and hypotension, as well as chronic conditions, such as hypertension, and systolic and diastolic left ventricular dysfunction presenting clinically as heart failure or cardiomyopathy. In cardio-oncology, when referring to cardiac toxicity and cardiovascular hypersensitivity, there is a great deal of misunderstanding...
March 18, 2024: Life
https://read.qxmd.com/read/38538818/cellular-electrophysiological-effects-of-the-citrus-flavonoid-hesperetin-in-dog-and-rabbit-cardiac-ventricular-preparations
#27
JOURNAL ARTICLE
Aiman Saleh A Mohammed, Gábor Mohácsi, Muhammad Naveed, János Prorok, Norbert Jost, László Virág, István Baczkó, Leila Topal, András Varró
Recent experimental data shows that hesperetin, a citrus flavonoid, affects potassium channels and can prolong the QTc interval in humans. Therefore, in the present study we investigated the effects of hesperetin on various transmembrane ionic currents and on ventricular action potentials. Transmembrane current measurements and action potential recordings were performed by patch-clamp and the conventional microelectrode techniques in dog and rabbit ventricular preparations. At 10 µM concentration hesperetin did not, however, at 30 µM significantly decreased the amplitude of the IK1 , Ito , IKr potassium currents...
March 27, 2024: Scientific Reports
https://read.qxmd.com/read/38528561/transcriptome-and-open-chromatin-analysis-reveals-the-process-of-myocardial-cell-development-and-key-pathogenic-target-proteins-in-long-qt-syndrome-type-7
#28
JOURNAL ARTICLE
Peipei Chen, Junyu Long, Tianrui Hua, Zhifa Zheng, Ying Xiao, Lianfeng Chen, Kang Yu, Wei Wu, Shuyang Zhang
OBJECTIVE: Long QT syndrome type 7 (Andersen-Tawil syndrome, ATS), which is caused by KCNJ2 gene mutation, often leads to ventricular arrhythmia, periodic paralysis and skeletal malformations. The development, differentiation and electrophysiological maturation of cardiomyocytes (CMs) changes promote the pathophysiology of Long QT syndrome type 7(LQT7). We aimed to specifically reproduce the ATS disease phenotype and study the pathogenic mechanism. METHODS AND RESULTS: We established a cardiac cell model derived from human induced pluripotent stem cells (hiPSCs) to the phenotypes and electrophysiological function, and the establishment of a human myocardial cell model that specifically reproduces the symptoms of ATS provides a reliable platform for exploring the mechanism of this disease or potential drugs...
March 25, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38519491/versatile-human-cardiac-tissues-engineered-with-perfusable-heart-extracellular-microenvironment-for-biomedical-applications
#29
JOURNAL ARTICLE
Sungjin Min, Suran Kim, Woo-Sup Sim, Yi Sun Choi, Hyebin Joo, Jae-Hyun Park, Su-Jin Lee, Hyeok Kim, Mi Jeong Lee, Inhea Jeong, Baofang Cui, Sung-Hyun Jo, Jin-Ju Kim, Seok Beom Hong, Yeon-Jik Choi, Kiwon Ban, Yun-Gon Kim, Jang-Ung Park, Hyang-Ae Lee, Hun-Jun Park, Seung-Woo Cho
Engineered human cardiac tissues have been utilized for various biomedical applications, including drug testing, disease modeling, and regenerative medicine. However, the applications of cardiac tissues derived from human pluripotent stem cells are often limited due to their immaturity and lack of functionality. Therefore, in this study, we establish a perfusable culture system based on in vivo-like heart microenvironments to improve human cardiac tissue fabrication. The integrated culture platform of a microfluidic chip and a three-dimensional heart extracellular matrix enhances human cardiac tissue development and their structural and functional maturation...
March 22, 2024: Nature Communications
https://read.qxmd.com/read/38519421/the-pharmacokinetics-and-pharmacodynamics-of-ibogaine-in-opioid-use-disorder-patients
#30
JOURNAL ARTICLE
Thomas Knuijver, Rob Ter Heine, Arnt F A Schellekens, Paniz Heydari, Luc Lucas, Sjoerd Westra, Maarten Belgers, Toon van Oosteren, Robbert Jan Verkes, Cornelis Kramers
OBJECTIVE: Ibogaine is a hallucinogenic drug that may be used to treat opioid use disorder (OUD). The relationships between pharmacokinetics (PKs) of ibogaine and its metabolites and their clinical effects on side effects and opioid withdrawal severity are unknown. We aimed to study these relationships in patients with OUD undergoing detoxification supported by ibogaine. METHODS: The study was performed in 14 subjects with OUD. They received a single dose of 10mg/kg ibogaine hydrochloride...
March 22, 2024: Journal of Psychopharmacology
https://read.qxmd.com/read/38516474/fluoroquinolones-neurological-complications-and-side-effects-in-clinical-practice
#31
REVIEW
Ahmed I Anwar, Lei Lu, Connor J Plaisance, Charles P Daniel, Chelsi J Flanagan, Danielle M Wenger, David McGregor, Giustino Varrassi, Adam M Kaye, Shahab Ahmadzadeh, Elyse M Cornett, Sahar Shekoohi, Alan D Kaye
Fluoroquinolones, a popular antibiotic class that inhibits nucleic acid synthesis of bacteria by disrupting the activity of the enzyme's topoisomerase IV and DNA gyrase, are used to treat bacterial infections. However, the widespread use of these drugs has allowed for the development of microbial resistance in recent years. Quinolones also have many clinically relevant side effects, including psychosis, confusion, seizures, headaches, dizziness, and nausea. Common side effects include tendinitis, myopathy, depression, and fatigue...
February 2024: Curēus
https://read.qxmd.com/read/38506312/genetic-risk-factors-for-drug-induced-long-qt-syndrome-findings-from-a-large-real-world-case-control-study
#32
JOURNAL ARTICLE
Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P Jacoby, Omer Berenfeld, Jasmine A Luzum
Aim: Drug-induced long QT syndrome (diLQTS), an adverse effect of many drugs, can lead to sudden cardiac death. Candidate genetic variants in cardiac ion channels have been associated with diLQTS, but several limitations of previous studies hamper clinical utility. Materials & methods: Thus, the purpose of this study was to assess the associations of KCNE1 -D85N, KCNE2 -I57T and SCN5A -G615E with diLQTS in a large observational case-control study (6,083 self-reported white patients treated with 27 different high-risk QT-prolonging medications; 12...
March 20, 2024: Pharmacogenomics
https://read.qxmd.com/read/38499113/pharmacokinetics-safety-and-tolerability-of-the-novel-tetrameric-gadolinium-based-mri-contrast-agent-gadoquatrane-in-healthy-chinese-and-japanese-men-two-randomized-dose-escalation-studies-including-concentration-qtc-modeling
#33
JOURNAL ARTICLE
Xuemei He, Shunji Matsuki, Kexin Li, Yubin Sui, Kumi Matsuno, Mengyuan Ren, Gabriele Sutter, Birte Maria Hofmann
PURPOSE: To investigate the pharmacokinetics, safety, and tolerability of the novel tetrameric high-relaxivity gadolinium-based contrast agent gadoquatrane in Japanese (Study 1) and Chinese men (Study 2). PARTICIPANTS AND METHODS: In two similarly designed single-center, randomized, single-blind, placebo-controlled, consecutive-cohort dose-escalation studies, healthy volunteers were randomly assigned to intravenous administration of gadoquatrane (0.01-0.1 mmol gadolinium/kg body weight) or placebo...
March 16, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38497379/an-evaluation-of-rezafungin-the-latest-treatment-option-for-adults-with-candidemia-and-invasive-candidiasis
#34
REVIEW
Divisha Sharma, Jose A Vazquez
INTRODUCTION: Invasive fungal infections, especially candidemia and invasive candidiasis, continue to cause substantial morbidity and mortality. In addition, the emergence of drug-resistant Candida species, notably C. glabrata and C. auris , along with limitations in available treatments, highlights the urgent need for novel, effective antifungal agents. AREAS COVERED: This review discusses the results of in vitro studies evaluating the spectrum and highlights the pharmacokinetic/pharmacodynamic properties...
March 18, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38489675/effect-of-lipid-emulsion-on-neuropsychiatric-drug-induced-toxicity-a-narrative-review
#35
REVIEW
Yeran Hwang, Ju-Tae Sohn
Lipid emulsion has been shown to effectively relieve refractory cardiovascular collapse resulting from toxic levels of nonlocal anesthetics. The goal of this study was to examine the effect of lipid emulsions on neuropsychiatric drug-induced toxicity using relevant case reports of human patients, with a particular focus on the Glasgow Coma Scale (GCS) score and corrected QT interval, to analyze drugs that frequently require lipid emulsion treatment. The following keywords were used to retrieve relevant case reports from PubMed: "antidepressant or antipsychotic drug or amitriptyline or bupropion or citalopram or desipramine or dosulepin or dothiepin or doxepin or escitalopram or fluoxetine or haloperidol or olanzapine or phenothiazine or quetiapine or risperidone or trazodone" and "lipid emulsion or Intralipid...
March 15, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38482864/a-real-world-pharmacovigilance-study-of-qt-interval-prolongation-and-torsades-de-pointes-associated-with-cdk4-6-inhibitors-in-breast-cancer-patients-findings-from-the-fda-adverse-event-reporting-system
#36
JOURNAL ARTICLE
Yu Yan, Bin Wu, Ling Wang
BACKGROUND: The aim of this study was to evaluate the association between CDK4/6 inhibitors and QT interval prolongation (QTp) and Torsades de Pointes (TdP) in breast cancer patients. METHOD: The cases with breast cancer from 2015 to 2022 were extracted from the FDA adverse event database (FARES) and further divided into a CDK4/6 inhibitor group and a positive control group. The associations between CDK4/6 inhibitors and QTp and TdP adverse events were evaluated using the reporting odds ratio (ROR) and the information component (IC)...
March 14, 2024: Expert Opinion on Drug Safety
https://read.qxmd.com/read/38479593/evaluation-of-the-translation-of-multiple-cardiovascular-regulatory-mechanisms-in-the-anesthetized-dog
#37
JOURNAL ARTICLE
Olivera Antic, Yevgeniya E Koshman, Brandan M Bird, Geena Jasiek, Amanda S Wilsey, Scott W Mittelstadt, C Michael Foley
The strategic and targeted use of an anesthetized canine cardiovascular model early in drug discovery enables a comprehensive cardiovascular and electrophysiological assessment of potential safety liabilities and guides compound selection prior to initiation of chronic toxicological studies. An ideal model would enable exposure-response relationships to guide safety margin calculations, have a low threshold to initiate, and have quick delivery of decision quality data. We have aimed to profile compounds with diverse mechanism of actions (MoAs) of "non-QT" cardiovascular drug effects and evaluate the ability of nonclinical in vivo cardiovascular models to detect clinically reported effects...
March 11, 2024: Journal of Pharmacological and Toxicological Methods
https://read.qxmd.com/read/38478383/investigating-the-association-between-cyp2j2-inhibitors-and-qt-prolongation-a-literature-review
#38
REVIEW
Alexandra M Wiley, Jade Yang, Rivcka Madhani, Abhinav Nath, Rheem A Totah
Drug withdrawal post-marketing due tocardiotoxicity is a major concern for drug developers, regulatory agencies, and patients. One common mechanism of cardiotoxicity isthroughinhibition of cardiac ion channels, leading to prolongation of the QT intervaland sometimes fatal arrythmias. Recently, oxylipinsignaling compounds have been shown to bind toand alter ion channel function,and disruption in their cardiac levels may contribute to QTprolongation. Cytochrome P450 2J2 (CYP2J2) is the predominant CYP isoform expressed in cardiomyocytes,where it oxidizes arachidonic acid to cardioprotectiveepoxyeicosatrienoic acids (EETs)...
March 13, 2024: Drug Metabolism Reviews
https://read.qxmd.com/read/38477622/-in-silico-human-cardiomyocyte-action-potential-modeling-exploring-ion-channel-input-combinations
#39
JOURNAL ARTICLE
Emmanuel Boulay, Eric Troncy, Vincent Jacquemet, Hai Huang, Michael K Pugsley, Anne-Marie Downey, Rafael Venegas Baca, Simon Authier
In silico modeling offers an opportunity to supplement and accelerate cardiac safety testing. With in silico modeling, computational simulation methods are used to predict electrophysiological interactions and pharmacological effects of novel drugs on critical physiological processes. The O'Hara-Rudy's model was developed to predict the response to different ion channel inhibition levels on cardiac action potential duration (APD) which is known to directly correlate with the QT interval. APD data at 30% 60% and 90% inhibition were derived from the model to delineate possible ventricular arrhythmia scenarios and the marginal contribution of each ion channel to the model...
March 13, 2024: International Journal of Toxicology
https://read.qxmd.com/read/38467517/tolerability-and-safety-outcomes-of-first-line-oral-second-generation-antipsychotics-in-patients-with-schizophrenia
#40
REVIEW
Kristen Ward, Leslie Citrome
INTRODUCTION: Antipsychotics are the foundation of pharmacologic treatment for schizophrenia. There are many oral antipsychotics available and given that these medications are generally considered comparably efficacious when titrated to an adequate dose, their varied tolerability and safety profiles become critically important for medication selection. AREAS COVERED: This paper reviews tolerability and safety considerations for first-line second-generation oral antipsychotics currently approved for the treatment of schizophrenia in the United States...
March 11, 2024: Expert Opinion on Drug Safety
keyword
keyword
82671
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.